Heidelberg Pharma AG (LON:0QW5)

Heidelberg Pharma AG Statistics

Total Valuation

LON:0QW5 has a market cap or net worth of GBP 115.53 million. The enterprise value is 95.55 million.

Market Cap	115.53M
Enterprise Value	95.55M

Important Dates

The next estimated earnings date is Monday, March 23, 2026.

Earnings Date	Mar 23, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	46.78M
Shares Outstanding	n/a
Shares Change (YoY)	+2.26%
Shares Change (QoQ)	-0.81%
Owned by Insiders (%)	2.36%
Owned by Institutions (%)	0.73%
Float	9.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	43.92
PB Ratio	12.67
P/TBV Ratio	78.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.21
EV / Sales	35.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.45

Financial Position

The company has a current ratio of 5.85, with a Debt / Equity ratio of 0.01.

Current Ratio	5.85
Quick Ratio	3.48
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-6,755.61

Financial Efficiency

Return on equity (ROE) is -112.95% and return on invested capital (ROIC) is -83.00%.

Return on Equity (ROE)	-112.95%
Return on Assets (ROA)	-32.31%
Return on Invested Capital (ROIC)	-83.00%
Return on Capital Employed (ROCE)	-65.82%
Revenue Per Employee	23,073
Profits Per Employee	-198,847
Employee Count	105
Asset Turnover	0.05
Inventory Turnover	0.03

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.42% in the last 52 weeks. The beta is -0.28, so LON:0QW5's price volatility has been lower than the market average.

Beta (5Y)	-0.28
52-Week Price Change	+15.42%
50-Day Moving Average	3.08
200-Day Moving Average	3.29
Relative Strength Index (RSI)	42.26
Average Volume (20 Days)	136

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0QW5 had revenue of GBP 2.63 million and -22.67 million in losses. Loss per share was -0.48.

Revenue	2.63M
Gross Profit	2.23M
Operating Income	-26.82M
Pretax Income	-22.67M
Net Income	-22.67M
EBITDA	-26.19M
EBIT	-26.82M
Loss Per Share	-0.48

Balance Sheet

The company has 19.80 million in cash and 113,352 in debt, giving a net cash position of 19.69 million.

Cash & Cash Equivalents	19.80M
Total Debt	113,352
Net Cash	19.69M
Net Cash Per Share	n/a
Equity (Book Value)	9.12M
Book Value Per Share	0.19
Working Capital	29.40M

Cash Flow

In the last 12 months, operating cash flow was -27.41 million and capital expenditures -293,926, giving a free cash flow of -27.71 million.

Operating Cash Flow	-27.41M
Capital Expenditures	-293,926
Free Cash Flow	-27.71M
FCF Per Share	n/a

Margins

Gross Margin	84.66%
Operating Margin	-1,019.65%
Pretax Margin	-861.83%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0QW5 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.26%
Shareholder Yield	-2.26%
Earnings Yield	-19.62%
FCF Yield	-23.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.

Last Split Date	Nov 7, 2017
Split Type	Forward
Split Ratio	1.0464082038

Scores

LON:0QW5 has an Altman Z-Score of -8.25 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.25
Piotroski F-Score	1